Skip to main content

GLP-1 Telehealth Providers: Price Terms and Program Questions

By the Peptide Dossier Editorial TeamUpdated How we source

This page compares advertised program terms and current quote questions for five GLP-1 telehealth providers. Pricing and availability can change; the table separates dated provider statements from details that remain unverified.

GLP-1 Provider Quotes and Terms

The table is a checklist for comparing a quote for a specific medication and prescribed dose. Confirm what the listed figure includes, when billing renews, and any fees or cancellation terms.

FeatureSurpassMDTrimRxFridaysHenry MedsRemedy Meds
Semaglutide (monthly)Promo from $114/mo; eligible patients; request full termsCurrent quote not verified; request termsCurrent medication quote not verifiedCurrent medication quote not verifiedCurrent medication quote not verified
Payment and renewal termsConfirm payment period and renewal totalCurrent prepay and renewal terms unverifiedFour-month promotion; confirm renewal termsSite describes monthly billing; confirm termsCurrent payment and renewal terms unverified
Tirzepatide (monthly)Promo from $177/mo; eligible patients; request full termsCurrent quote not verified; request termsRequest quote for exact current productCurrent medication quote not verifiedCurrent medication quote not verified
Oral optionSite lists oral semaglutide; clinician decidesConfirm formulation and current availabilityConfirm formulation and current availabilityConfirm formulation and current availabilityConfirm formulation and current availability
Medication and dose price termsFlat pricing across doses for each medicationCurrent dose-dependent terms unverifiedCurrent dose-dependent terms unverifiedCurrent dose-dependent terms unverifiedCurrent dose-dependent terms unverified
ShippingSite says within 48 hours after approvalRequest dispatch and delivery termsRequest dispatch and delivery termsRequest dispatch and delivery termsRequest dispatch and delivery terms
Nutrition and support scopeConfirm nutrition services included in quoteConfirm consultation and support scopeSite lists dietitians; confirm plan scopeConfirm consultation and support scopeConfirm messaging and clinician-check-in terms
Insurance help (brand meds)Cash-pay; ask about beneficiary restrictionsConfirm insurer and payment termsSite describes insurance help; confirm scopeConfirm insurer and payment termsConfirm insurer and payment terms
CoverageSite lists 50 states + DC; services varyCurrent service area not verifiedConfirm current service area and eligibilityConfirm current service area and eligibilityConfirm current service area and eligibility

Provider website statements are dated self-reports, not independent tests of price, delivery, or clinical outcomes. The exact preparation and prescribing decision matter.

SurpassMD: Advertised Price Terms and Care Questions

On October 12, 2026, SurpassMD’s website advertised promotional starting prices for eligible patients, subject to provider approval; the offer has flat pricing across doses for each medication. Other table entries are dated site statements or questions for the provider.

For program details, read our full SurpassMD review.

Questions: Which medication offer applies, and what payment, renewal, and cancellation terms are in writing?

TrimRx: Current Quote Needed

Direct review of TrimRx’s named domain did not produce a usable current quote. Medication prices, dose terms, payment cycle, current product availability, and service area remain unverified here. Request an itemized quote identifying medication, prescribed dose, fees, renewal, cancellation, and dispensing pharmacy.

Questions: Which current written quote and renewal terms apply? See our full TrimRx review.

Fridays: Program and Membership Terms

On October 27, 2026, Fridays’ site described a four-month membership promotion with a 25% discount that renews at the then-current discounted rate, subject to clinical eligibility. It describes dietitian access and help with insurance paperwork for brand-name medication; confirm whether those services and any fee apply to the selected plan.

Questions: What does the membership cover, how does its renewal work, and what current medication quote applies? The provider’s promotion terms distinguish membership billing from a guaranteed prescription. See our full Fridays review.

Henry Meds: Product and Billing Questions

On October 12, 2026, Henry Meds’ website described monthly billing with provider review and medication and supplies included. This page did not verify a fixed semaglutide or tirzepatide quote, a particular dose, or current product availability. Request the total recurring price and the terms for the exact medication and prescription.

Questions: Which medication and dose are currently offered, what is the full recurring price, and what review applies? See our full Henry Meds review.

Remedy Meds: Claims, Terms and Dated FDA Context

On October 12, 2026, Remedy Meds’ website marketed compounded GLP-1 programs; its clinical claims are not outcome evidence. FDA’s September 9, 2025 letter describes an August 2025 website review and objects to implications that compounded semaglutide or tirzepatide was the same as an approved drug. This dated letter does not establish current status or resolution.

Questions: What current product, price, billing, and clinician-review terms apply? See our full Remedy Meds review.

How to Choose a GLP-1 Telehealth Provider

Before enrolling, request the complete recurring cost for the exact medication and prescribed dose, renewal and cancellation rules, dispensing pharmacy, and expected dispatch and delivery terms. Ask which entity evaluates the prescription and what regulatory basis applies to the specific preparation; 503A and 503B settings are not interchangeable labels for identical oversight.

For deeper pricing context, see our guides to compounded semaglutide cost, compounded tirzepatide cost, and the full GLP-1 telehealth price comparison. For head-to-head matchups, see SurpassMD vs Henry Meds, SurpassMD vs TrimRx, SurpassMD vs Fridays, and SurpassMD vs Remedy Meds.

Verify current program details directly with the provider and prescribing clinician before submitting an intake. Published service-area, product, payment, and shipping statements can change and do not establish personal eligibility or fulfillment. Our GLP-1 Program Guide provides a framework to compare online care programs and included support.

Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Ownership disclosure.

Frequently Asked Questions

The available pages do not support a verified cheapest-provider ranking. Compare an itemized quote for the exact medication and prescribed dose, payment and renewal period, fees, and cancellation terms; advertised starting figures are not complete comparable quotes.

This comparison cannot determine eligibility or guarantee a prescription. Ask each provider how its intake and independent clinical review work, which pharmacy would dispense, and what the specific program includes.

Compounded drugs are not FDA-approved. A compounded preparation is not an FDA-approved generic version of a branded drug.

The pages reviewed do not establish one insurance rule across providers. Ask whether the specific program bills your plan, whether any help is limited to paperwork for brand-name medication, and what you would owe if coverage is denied.

The available information does not establish which provider delivers fastest. Request the dispatch cutoff and carrier estimate, and distinguish a dispatch target from the date medication arrives.

Ask both prescribing clinicians how they will review your records and whether a new prescription is appropriate. Do not change medication or dose based on a vendor comparison; confirm continuity and timing directly with your clinician.

A prescription is not guaranteed. Ask the evaluating provider what follow-up or other options are appropriate for your circumstances; eligibility and clinical decisions belong to that provider.

Cayman lists retatrutide for research use in its catalog; its product says it is not for human or veterinary use. These examples do not establish every peptide or vendor.

FDA says compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality. FDA describes separate 503A and 503B frameworks; verify the entity and preparation that would dispense.